HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoming Zhang Selected Research

Toll-Like Receptor 4

11/2013MD-2 is involved in the stimulation of matrix metalloproteinase-1 expression by interferon-γ and high glucose in mononuclear cells - a potential role of MD-2 in Toll-like receptor 4-independent signalling.
1/2013TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
7/2012Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6.
12/2011TLR4 activation and IL-6-mediated cross talk between adipocytes and mononuclear cells synergistically stimulate MMP-1 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoming Zhang Research Topics

Disease

64Neoplasms (Cancer)
05/2024 - 08/2004
27Inflammation (Inflammations)
02/2024 - 05/2007
17Infections
01/2024 - 02/2009
15Chronic Renal Insufficiency
04/2023 - 07/2012
12Fibrosis (Cirrhosis)
12/2023 - 08/2010
10COVID-19
04/2024 - 01/2020
10Neoplasm Metastasis (Metastasis)
01/2024 - 01/2013
10Dehydration (Water Stress)
11/2023 - 09/2018
9Heart Failure
11/2023 - 07/2014
9Insulin Resistance
08/2023 - 09/2010
9Breast Neoplasms (Breast Cancer)
09/2022 - 12/2009
8Glioma (Gliomas)
01/2022 - 08/2004
7Carcinoma (Carcinomatosis)
01/2023 - 10/2012
7Spinal Cord Injuries (Spinal Cord Injury)
11/2017 - 06/2009
6Aortic Dissection
04/2024 - 05/2009
6Hypertension (High Blood Pressure)
10/2023 - 07/2012
6Carcinogenesis
12/2022 - 01/2019
5Body Weight (Weight, Body)
01/2023 - 01/2008
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2014
5Thoracic Aortic Aneurysm
01/2022 - 08/2015
5Cognitive Dysfunction
04/2020 - 08/2007
5Hyperglycemia
01/2020 - 01/2013
5Atherosclerosis
11/2015 - 07/2012
4Hypertrophy
02/2024 - 09/2016
4Mycoses (Diseases, Fungus)
01/2024 - 06/2015
4Melanoma (Melanoma, Malignant)
01/2024 - 01/2005
4Peripheral Arterial Disease
01/2024 - 11/2015
4Endometrioid Carcinoma
01/2023 - 11/2013
4Communicable Diseases (Infectious Diseases)
11/2022 - 03/2011
4Chronic Kidney Failure (Chronic Renal Failure)
07/2020 - 07/2014
4Albuminuria
02/2020 - 08/2015
4Hypoxia (Hypoxemia)
12/2019 - 01/2016
4Proteinuria
01/2019 - 02/2014
3Wounds and Injuries (Trauma)
02/2024 - 01/2019
3Vascular Diseases (Vascular Disease)
01/2024 - 11/2014
3Virus Diseases (Viral Diseases)
12/2023 - 03/2014
3Sarcopenia
11/2023 - 11/2018
3Pathologic Constriction (Stenosis)
08/2023 - 05/2019
3Obesity
08/2023 - 12/2011
3CDKL5 deficiency disorder
01/2023 - 01/2019
3Thrombosis (Thrombus)
01/2023 - 05/2019
3Hypokalemia
12/2022 - 01/2020
3Lung Neoplasms (Lung Cancer)
09/2022 - 12/2019
3Renal Insufficiency (Renal Failure)
01/2022 - 01/2019
3Sepsis (Septicemia)
01/2022 - 11/2018

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
02/2024 - 03/2003
20Biomarkers (Surrogate Marker)IBA
02/2024 - 06/2014
13RNA (Ribonucleic Acid)IBA
12/2023 - 02/2010
12MicroRNAs (MicroRNA)IBA
12/2023 - 01/2011
9VaccinesIBA
04/2024 - 02/2009
9AntigensIBA
02/2024 - 11/2010
9LipopolysaccharidesIBA
08/2021 - 01/2013
7Antiviral Agents (Antivirals)IBA
04/2024 - 01/2013
7Glucose (Dextrose)FDA LinkGeneric
07/2023 - 11/2013
7CytokinesIBA
01/2023 - 07/2012
7Messenger RNA (mRNA)IBA
06/2022 - 03/2003
7Long Noncoding RNAIBA
06/2022 - 01/2019
6Oxygen (Dioxygen)IBA
11/2023 - 11/2014
6CreatinineIBA
04/2023 - 01/2016
6Competitive Endogenous RNAIBA
12/2022 - 01/2020
5Interleukin-6 (Interleukin 6)IBA
02/2024 - 01/2013
5Hemoglobins (Hemoglobin)IBA
01/2024 - 01/2017
5EnzymesIBA
01/2024 - 12/2019
5Transcription Factors (Transcription Factor)IBA
12/2023 - 12/2009
5Streptozocin (Streptozotocin)FDA Link
11/2022 - 08/2007
5C-Reactive ProteinIBA
01/2020 - 07/2012
4Histones (Histone)IBA
02/2024 - 01/2013
41-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2024 - 12/2014
4Anti-Bacterial Agents (Antibiotics)IBA
08/2023 - 01/2018
4AcidsIBA
07/2023 - 07/2012
41,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
01/2022 - 01/2019
4Xylose (D-Xylose)FDA Link
12/2021 - 09/2018
4InterferonsIBA
01/2020 - 05/2007
4Triglycerides (Triacylglycerol)IBA
12/2018 - 01/2013
4Matrix Metalloproteinases (MMPs)IBA
06/2014 - 05/2009
4Toll-Like Receptor 4IBA
11/2013 - 12/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2024 - 09/2016
3Hydrocortisone (Cortisol)FDA LinkGeneric
02/2024 - 07/2014
3Fibrinogen (Factor I)FDA Link
01/2024 - 07/2012
3AlbuminsIBA
01/2024 - 01/2016
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2024 - 03/2003
3ferric oxide (iron oxide)IBA
01/2024 - 12/2022
3CalciumIBA
12/2023 - 01/2018
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2023 - 09/2019
3Adrenocorticotropic Hormone (ACTH)FDA Link
01/2023 - 06/2022
3Therapeutic UsesIBA
10/2022 - 08/2015
3AntibodiesIBA
09/2022 - 11/2020
3AntioxidantsIBA
07/2022 - 04/2016
3Dexamethasone (Maxidex)FDA LinkGeneric
06/2022 - 01/2021
3Circular RNAIBA
06/2022 - 01/2020
3Transforming Growth Factor beta (TGF-beta)IBA
11/2021 - 06/2009

Therapy/Procedure

34Therapeutics
02/2024 - 02/2010
9Immunotherapy
05/2024 - 04/2011
8Stents
04/2024 - 11/2015
5Photochemotherapy (Photodynamic Therapy)
01/2024 - 12/2014
5Drug Therapy (Chemotherapy)
01/2022 - 01/2013
4Lasers (Laser)
01/2024 - 12/2014
4Endovascular Aneurysm Repair
02/2023 - 07/2016
3Anesthesia
08/2023 - 08/2012
3Intravenous Administration
08/2023 - 12/2022